Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors.
Zhu Y, Pei X, Novaj A, Setton J, Bronder D, Derakhshan F, Selenica P, McDermott N, Orman M, Plum S, Subramanyan S, Braverman SH, McMillan B, Sinha S, Ma J, Gazzo A, Khan A, Bakhoum S, Powell SN, Reis-Filho JS, Riaz N.
Zhu Y, et al. Among authors: plum s.
Genome Med. 2024 Aug 28;16(1):108. doi: 10.1186/s13073-024-01371-y.
Genome Med. 2024.
PMID: 39198848
Free PMC article.